Literature DB >> 19105032

Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matrices.

Matthew Rees1, Lloyd Sansom, Allan Rofe, Albert L Juhasz, Euan Smith, John Weber, Ravi Naidu, Tim Kuchel.   

Abstract

The assessment of arsenic (As) bioavailability from contaminated matrices is a crucial parameter for reducing the uncertainty when estimating exposure for human health risk assessment. In vivo assessment of As utilising swine is considered an appropriate model for human health risk assessment applications as swine are remarkably similar to humans in terms of physiology and As metabolism. While limited in vivo As bioavailability data is available in the literature, few details have been provided regarding technical considerations for performing in vivo assays. This paper describes, with examples, surgical, experimental design and analytical issues associated with performing chronic and acute in vivo swine assays to determine As bioavailability in contaminated soil and food.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19105032     DOI： 10.1007/s10653-008-9237-y

Source DB:  PubMed          Journal:  Environ Geochem Health        ISSN： 0269-4042            Impact factor:   4.609


  21 in total

1.  Arsenic in drinking water and incidence of urinary cancers.

Authors:  H R Guo; H S Chiang; H Hu; S R Lipsitz; R R Monson
Journal:  Epidemiology       Date:  1997-09       Impact factor: 4.822

2.  Technique of venous catheterization for sequential blood sampling from the pig.

Authors:  S A Bain; J Ting; C J Simeonovic; J D Wilson
Journal:  J Invest Surg       Date:  1991       Impact factor: 2.533

3.  Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites.

Authors:  Iván Csanaky; Zoltán Gregus
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2002-03       Impact factor: 3.228

4.  Surgical procedure for chronic biliary sample collection in pigs.

Authors:  J C Thurmon; D R Nelson; R F Bevill; G W Harrington; D N Magee
Journal:  Am J Vet Res       Date:  1987-06       Impact factor: 1.156

5.  Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats.

Authors:  Z Gregus; A Gyurasics; I Csanaky
Journal:  Toxicol Sci       Date:  2000-07       Impact factor: 4.849

6.  Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India.

Authors:  D N Guha Mazumder; R Haque; N Ghosh; B K De; A Santra; D Chakraborty; A H Smith
Journal:  Int J Epidemiol       Date:  1998-10       Impact factor: 7.196

7.  Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys.

Authors:  G B Freeman; R A Schoof; M V Ruby; A O Davis; J A Dill; S C Liao; C A Lapin; P D Bergstrom
Journal:  Fundam Appl Toxicol       Date:  1995-12

8.  Glutathione-dependent biliary excretion of arsenic.

Authors:  A Gyurasics; F Varga; Z Gregus
Journal:  Biochem Pharmacol       Date:  1991-07-15       Impact factor: 5.858

9.  Comparison of in vivo and in vitro methodologies for the assessment of arsenic bioavailability in contaminated soils.

Authors:  Albert L Juhasz; Euan Smith; John Weber; Matthew Rees; Allan Rofe; Tim Kuchel; Lloyd Sansom; Ravi Naidu
Journal:  Chemosphere       Date:  2007-06-21       Impact factor: 7.086

10.  Bioavailability of inorganic arsenic from bog ore-containing soil in the dog.

Authors:  K Groen; H A Vaessen; J J Kliest; J L de Boer; T van Ooik; A Timmerman; R F Vlug
Journal:  Environ Health Perspect       Date:  1994-02       Impact factor: 9.031
View more
  8 in total

1.  Arsenic in the environment--risks and management strategies.

Authors:  Ravi Naidu; Prosun Bhattacharya
Journal:  Environ Geochem Health       Date:  2009-01-16       Impact factor: 4.609

2.  Intra- and Interlaboratory Evaluation of an Assay of Soil Arsenic Relative Bioavailability in Mice.

Authors:  Karen Bradham; Carina Herde; Paul Herde; Albert L Juhasz; Karen Herbin-Davis; Brittany Elek; Amy Farthing; Gary L Diamond; David J Thomas
Journal:  J Agric Food Chem       Date:  2020-02-19       Impact factor: 5.279

3.  Modification of an existing in vitro method to predict relative bioavailable arsenic in soils.

Authors:  Shane Whitacre; Nicholas Basta; Brooke Stevens; Valerie Hanley; Richard Anderson; Kirk Scheckel
Journal:  Chemosphere       Date:  2017-04-03       Impact factor: 7.086

4.  Interaction effects of lead on bioavailability and pharmacokinetics of arsenic in the rat.

Authors:  Violet Diacomanolis; Barry N Noller; Jack C Ng
Journal:  Environ Geochem Health       Date:  2013-06-01       Impact factor: 4.609

5.  Relative bioavailability and bioaccessibility and speciation of arsenic in contaminated soils.

Authors:  Karen D Bradham; Kirk G Scheckel; Clay M Nelson; Paul E Seales; Grace E Lee; Michael F Hughes; Bradley W Miller; Aaron Yeow; Thomas Gilmore; Sophia M Serda; Sharon Harper; David J Thomas
Journal:  Environ Health Perspect       Date:  2011-07-13       Impact factor: 9.031

6.  Assessment of In Vitro Bioaccessibility and In Vivo Oral Bioavailability as Complementary Tools to Better Understand the Effect of Cooking on Methylmercury, Arsenic, and Selenium in Tuna.

Authors:  Tania Charette; Danyel Bueno Dalto; Maikel Rosabal; J Jacques Matte; Marc Amyot
Journal:  Toxics       Date:  2021-02-03

Review 7.  In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment.

Authors:  Karen D Bradham; Gary L Diamond; Michele Burgess; Albert Juhasz; Julie M Klotzbach; Mark Maddaloni; Clay Nelson; Kirk Scheckel; Sophia M Serda; Marc Stifelman; David J Thomas
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2018       Impact factor: 8.071

Review 8.  Arsenic and Environmental Health: State of the Science and Future Research Opportunities.

Authors:  Danielle J Carlin; Marisa F Naujokas; Karen D Bradham; John Cowden; Michelle Heacock; Heather F Henry; Janice S Lee; David J Thomas; Claudia Thompson; Erik J Tokar; Michael P Waalkes; Linda S Birnbaum; William A Suk
Journal:  Environ Health Perspect       Date:  2015-11-20       Impact factor: 9.031
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.